|
|
| HITRIplus Newsletter |
| October 2023 |
|
|
|
|
Dear Readers,
We are thrilled to bring you this month's newsletter, filled with groundbreaking updates and insights from the world of hadrontherapy. From the pioneering CME event directed by esteemed professionals and organized with IAEA and HITRIplus, to the record-breaking PTCOG 61 conference in Madrid, we cover the latest advancements and collaborations shaping the future of cancer treatment. Don't miss the highlights from the Third HITRIplus Project Meeting in Riga, which offered a platform for discussing technology transfer, industry relations, and educational activities. Lastly, we delve into the enriching internships and secondments offered by HITRIplus, providing hands-on experience in various specialized fields.
We look forward to your continued engagement as we explore the evolving landscape of hadrontherapy and related technologies.
The HITRIplus Communications Team |
|
|
|
|
 |
| Hadrontherapy: status and perspectives. Development of a hadrontherapy facility: learning from the existing and Scientific day on BNCT |
October 11th, 12th 13th, 2023
Don’t miss the opportunity to follow online this pioneering CME event.
Participation is free. Register online at the following address
https://fad.accmed.org/course/info.php?id=1325
Directed by esteemed professionals Ester Orlandi, Saverio Altieri, and Sotirios Charisopoulos, the event is organized with IAEA and HITRIplus and it’s addressed to all health professions.
Thanks to the participation of a panel of nationally and internationally renowned speakers, the workshop aims to:
- Expanding participants’ knowledge about clinical indications and advantages of hadrontherapy in an international overview and perspectives
- Informing participants on managerial, technical and clinical aspect of an hadrontherapy facility
- Improving understanding on resource requirements, challenges, economical and social implications of hadrontherapy
- Presenting status and perspectives of a new research clinical modality, BNCT (Boron Neutron Capture Therapy)
Discover the groundbreaking program:
https://fondazionecnao.it/uploads/2023-9-13/LONG_Handrotherapy_1109.pdf
We look forward to your participation in this pivotal event that aims to shape the future of Hadrontherapy and related technologies.
FEW PLACES STILL AVAILABLE!
|
|
|
|
|
 |
| HITRIplus Makes Waves at PTCOG 61: Record-Breaking Participation and Pioneering European Initiatives in Particle Therapy |
| HITRIplus was present at the 61st Annual Particle Therapy Co-Operative Group Conference (PTCOG 61) in Madrid, on May 12-15. An outstanding meeting that broke all records in terms of participation and number of abstracts, demonstrating the amazing growth of the particle treatment community. |
|
|
|
|
 |
| Advancing the Future of Cancer Treatment: Highlights from the Third HITRIplus Project Meeting in Riga |
| From June 26 to June 28, in the beautiful and picturesque setting of Riga, RTU hosted the Third HITRIplus Project Meeting. The meeting was an excellent opportunity to network and share perspectives on Heavy Ion Therapy Research: it was a memorable and engaging experience for all the participants. |
|
|
|
|
 |
| HITRIplus internships and secondments |
Contribution by: Nicholas Sammut
As part of its goal to train and educate a new generation of researchers in Heavy Ion Therapy, HITRIplus provided opportunities for postgraduate university students, postdocs, researchers and oncologists, to spend a few weeks at one of the European heavy ion therapy research infrastructures and hence gain hands-on experience. |
|
|
|
|
|
You receive this email as you subscribed to HITRIplus general newsletter in order to receive, via email, information and news about the activities of the HITRIplus Project, including invitations to participate in events or surveys and fundraising campaigns.
You can read more information about this data processing here: https://www.hitriplus.eu/privacy_policy/7410/
You can always opt-out selecting the unsubscribe option above.
petya.georgieva@cern.ch
©2023 HITRIplus |
|
|
|
